NOI - RCT NHP Sepsis Blood Samples

SOL #: 75N98026Q00547Combined Synopsis/Solicitation

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH OLAO
BETHESDA, MD, 20892, United States

Place of Performance

Place of performance not available

NAICS

Testing Laboratories and Services (541380)

PSC

Reference Laboratory Testing (Q301)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 8, 2026
2
Submission Deadline
Jun 15, 2026, 1:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to award a non-competitive, brand-name firm-fixed-price purchase order to Metabolon, Inc. for high-resolution, untargeted metabolomics analysis. This effort supports the National Heart, Lung, and Blood Institute (NHLBI) in characterizing neutrophil metabolic profiles from a non-human primate (NHP) bacterial sepsis model. Proposals are due June 15, 2026.

Scope of Work

This requirement is for high-resolution, untargeted metabolomics analysis utilizing the Metabolon global metabolomics platform. The service will analyze plasma samples derived from an NHP bacterial sepsis model. The platform must detect and quantify over 5,000–6,000 biochemicals across diverse metabolic pathways, including central carbon, lipid, amino acid, and inflammatory networks. The analytical workflow encompasses automated sample preparation, high-resolution mass spectrometry, advanced compound identification, metabolite extraction, profiling, identification, annotation, quantification, data normalization, quality control, batch correction, and delivery of raw/processed datasets. The use of the Metabolon platform is critical for scientific continuity to avoid batch effects and ensure longitudinal integration.

Contract & Timeline

  • Contract Type: Firm-Fixed-Price Purchase Order (non-competitive)
  • Period of Performance: Six (6) months after receipt of order (ARO)
  • Estimated Value: Not expected to exceed the simplified acquisition threshold.
  • NAICS Code: 541380, Testing Laboratories and Services ($19.0 million size standard).
  • Set-Aside: Not set aside for small business.
  • Response Due: Monday, June 15, 2026, at 9:00 AM EDT.
  • Published: June 8, 2026.

Submission & Evaluation

  • Submission Method: Electronically to nicholas.capobianco@nih.gov.
  • Required Information: Respondents must demonstrate capability and include unit price, list price, shipping/handling costs, delivery timeframe, prompt payment discount terms, F.O.B. point, product/catalog numbers, product descriptions, Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. Offerors must be registered in SAM.gov and include a completed copy of FAR 52.212-3.
  • Evaluation Factors: May include past performance, technical capability, special features, trade-ins, lifecycle, warranty, maintenance, and environmental/energy efficiency.

Additional Notes

This is a combined synopsis/solicitation (Notice of Intent) prepared under FAR Subpart 12.6. The solicitation number is 75N98026Q00547.

People

Points of Contact

CAPOBIANCO, NICHOLAS SPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Combined Synopsis/Solicitation
Posted: Jun 8, 2026
NOI - RCT NHP Sepsis Blood Samples | GovScope